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Abstract
Background: Little is known about the process of knowledge translation in low- and middle-
income countries. We studied policymaking processes in Mozambique, South Africa and Zimbabwe
to understand the factors affecting the use of research evidence in national policy development,
with a particular focus on the findings from randomized control trials (RCTs). We examined two
cases: the use of magnesium sulphate (MgSO4) in the treatment of eclampsia in pregnancy (a clinical
case); and the use of insecticide treated bed nets and indoor residual household spraying for malaria
vector control (a public health case).
Methods: We used a qualitative case-study methodology to explore the policy making process.
We carried out key informants interviews with a range of research and policy stakeholders in each
country, reviewed documents and developed timelines of key events. Using an iterative approach,
we undertook a thematic analysis of the data.
Findings:  Prior experience of particular interventions, local champions, stakeholders and
international networks, and the involvement of researchers in policy development were important
in knowledge translation for both case studies. Key differences across the two case studies included
the nature of the evidence, with clear evidence of efficacy for MgSO4 and ongoing debate regarding
the efficacy of bed nets compared with spraying; local researcher involvement in international
evidence production, which was stronger for MgSO4 than for malaria vector control; and a long-
standing culture of evidence-based health care within obstetrics. Other differences were the
importance of bureaucratic processes for clinical regulatory approval of MgSO4, and regional
Published: 30 December 2009
Health Research Policy and Systems 2009, 7:31 doi:10.1186/1478-4505-7-31
Received: 28 August 2009
Accepted: 30 December 2009
This article is available from: http://www.health-policy-systems.com/content/7/1/31
© 2009 Woelk et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Health Research Policy and Systems 2009, 7:31 http://www.health-policy-systems.com/content/7/1/31
Page 2 of 14
(page number not for citation purposes)
networks and political interests for malaria control. In contrast to treatment policies for eclampsia,
a diverse group of stakeholders with varied interests, differing in their use and interpretation of
evidence, was involved in malaria policy decisions in the three countries.
Conclusion:  Translating research knowledge into policy is a complex and context sensitive
process. Researchers aiming to enhance knowledge translation need to be aware of factors
influencing the demand for different types of research; interact and work closely with key policy
stakeholders, networks and local champions; and acknowledge the roles of important interest
groups.
Background
The evidence-based medicine approach, which focused
initially on clinical decision-making, has more recently
been extended to policy and management decisions,
where it is sometimes referred to as 'evidence-based' or
'evidence-informed' policy making [1-3]. Increasingly, the
use of global research evidence is being seen as a key com-
ponent of policy making processes and it has been sug-
gested widely that health goals are more likely to be
achieved by policies that are informed by rigorous
research evidence [4-8]. The evidence-informed policy
making approach suggests that research evidence from the
evaluation of health care interventions, particularly evi-
dence from systematic reviews of randomised controlled
trials (RCTs), is the most robust form of evidence for
informing policy decisions about the allocation of
resources to services or programmes as well as decisions
on how to deliver and finance these services [9-11]. How-
ever, there is still uncertainty about how research evidence
is used by policy makers and how best to ensure that avail-
able knowledge is translated into policies and actions.
Knowledge translation - defined as the "exchange, synthe-
sis, and effective communication of reliable and relevant
research results" [8] p.140) is particularly pertinent in
low- and middle-income countries (LMICs), which face
scarce resources as well as high disease burdens. Effective
and affordable interventions are available for many of the
health problems contributing to the disease burden in
these countries. However, this has not led to the auto-
matic translation of research evidence into policy-making
[4,12-14]; often these interventions are not implemented
or are discarded in favour of unproven interventions.
As three publications from the World Health Organiza-
tion indicate [8,15,16], growing attention is being paid to
knowledge translation in global health. Studies suggest
that the relationship between knowledge production
(research that generates evidence) and knowledge transla-
tion is complex [17,18] with a multitude of factors oper-
ating at the individual, organizational, systems and
contextual levels [19].
This paper aims to contribute to understanding the proc-
ess of knowledge translation in LMICs by describing the
factors affecting the use of research findings, particularly
findings from RCTs, in national policy development. It
also explores how actors in the policy process understand
the notion of 'evidence' for decision-making. The paper
focuses on policy making for two case studies: the use of
magnesium sulphate (MgSO4) in the treatment of
eclampsia and severe pre-eclampsia in pregnancy; and the
use of insecticide treated bed nets and indoor residual
household spraying for malaria vector control. These case
studies represent two different types of interventions: a
hospital or clinically based intervention for the treatment
of eclampsia and a public health or community based
intervention in the case of malaria control. The study
explores and compares the perceptions of stakeholders
involved in research and policy making in the two cases in
Mozambique, South Africa and Zimbabwe.
The case studies
MgSO4 for the treatment of eclampsia and severe pre-
eclampsia
Pre-eclampsia and eclampsia are important contributors
to maternal and infant morbidity and mortality in low-
income countries [20-22]. Strong evidence is available
from RCTs of the effectiveness of MgSO4 for women with
eclampsia and severe pre-eclampsia [23-27]. However,
there is concern that this safe, inexpensive drug may still
not be available or used widely in many countries [18,28-
30]. Ensuring that policies and actions are informed by
these RCT results could benefit many women.
Insecticide treated bed nets compared with indoor residual 
spraying for the control of malaria
Malaria remains a major contributor to the burden of dis-
ease in low-income countries [31]. RCTs have demon-
strated the effectiveness of insecticide treated bed nets in
reducing malaria incidence in endemic regions [32].
However, there are still controversies regarding the sus-
tainability of bed net programmes and their relative effec-
tiveness compared to traditional indoor residual
household spraying with insecticides [33-35]. Decision-
makers need to assess these uncertainties in developingHealth Research Policy and Systems 2009, 7:31 http://www.health-policy-systems.com/content/7/1/31
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policies and scaling up interventions for malaria preven-
tion.
Methods
We used a qualitative case-study methodology to explore
evidence uptake in the policy making process at national
level [36]. We did not consider how policies were imple-
mented in clinical medicine or public health but rather
focused on the upstream policy making process. In each
country, we undertook key informant interviews with key
stakeholders (Table 1), reviewed documents and devel-
oped timelines of key events. The regionally-based
research team consisted of four researchers in Mozam-
bique, and two each in South Africa and Zimbabwe.
Country selection
These three countries were partners in PraCTiHC (Prag-
matic Randomized Controlled Trials in Health Care), a
project funded by the European Commission. They are
low- and middle-income countries, where eclampsia and
malaria are important health problems and where health
care systems and policies have often undergone a signifi-
cant process of re-evaluation after independence or
regime change. Although there are significant regional
similarities between the three study countries, there are
also differences in health systems and resources; in current
and past policies with regard to malaria control and the
treatment of preclampsia/eclampsia; and in their relation-
ships to national and international policy networks.
Including these countries helped to illuminate the simi-
larities and differences in policy making across different
settings, thereby improving the generalisability of the
study findings.
Data Collection
Document Review
We reviewed documents that provided insight into policy
processes at country level. These included both formal
policy documents and other official documents such as
treatment guidelines, essential drugs lists, circulars, and
minutes of meetings.
Key Informant Interviews
We conducted interviews between April 2004 and March
2005, based on an interview guide that explored the pol-
icy development process. This guide was translated into
Portuguese in Mozambique, and most interviews in this
country were conducted in this language. English was the
language used for the interviews in South Africa and Zim-
babwe. Interviews took about 45 minutes. We audio-
recorded each interview and transcribed the recordings in
their original language.
We used a combination of purposive and snowball sam-
pling to select key informants [37], based on their involve-
ment in research or policy making for each case study
Table 1: Profile of study respondents
Country Number of respondents
MgSO4 case study Malaria case study
Mozambique
Government health officials 4 4
Pharmaceutical policy makers* 5
NGOs 3
Clinicians/researchers 5 7
International/bilateral agencies 5
South Africa:
Government health officials 5 8
NGOs 2
Clinicians/researchers 10 4
International/bilateral agencies 1
Zimbabwe
Government health officials 2 4
Pharmaceutical policy makers* 7
Pharmaceutical company representatives 3
Clinician/researchers 7 2
International/bilateral agencies 4
Researchers based outside of the study settings 13
*Pharmaceutical policy makers sat on national bodies that determined policy.Health Research Policy and Systems 2009, 7:31 http://www.health-policy-systems.com/content/7/1/31
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(Table 1). An iterative approach to data collection and
analysis was used, with themes and issues emerging from
early interviews explored further in later interviews. We
stopped recruiting respondents once we felt that we had
reached data saturation [37].
Timelines
For each policy case study, we constructed a timeline of
key events in the policy process, including important
meetings and the publication of policy documents and
research findings. Initially we drafted each timeline based
on available documents and on our knowledge of each
policy context. Each timeline was then refined using infor-
mation gained from the document review and interviews.
We further corroborated dates and events by searching the
internet and through consultation with colleagues famil-
iar with the events.
Data Analysis and Interpretation
In order to manage the large data set generated, we used a
multilayered approach to data analysis. Analysis began
with the data generated from the key informant inter-
views. Country level researchers read and annotated each
transcript and identified preliminary themes. These
themes reflected issues arising from the interviews and
document analyses. We then held a joint workshop where
we discussed broad themes emerging across the country
data, thus devising a preliminary coding scheme to guide
further thematic analysis. These steps were taken to har-
monize the analysis process across the study sites. It also
facilitated later cross-country and cross-case study analy-
sis. We then undertook further thematic analysis of the
data, based on this coding scheme. Once coded, we
grouped data extracts from each transcript together under
the appropriate category. After reading and re-reading the
coded data, a narrative account of the findings was devel-
oped. For the write-up, we selected data extracts illustra-
tive of the key themes. To enhance the validity of the
study, our research process included internal training of
the research team, respondent validation or member
checks and attention to negative cases [38]. In addition,
we paid considerable attention to exploring similarities
and differences in knowledge translation processes
between the two case studies and across the three coun-
tries.
Ethical approval
The study received approval from ethics committees at the
Medical Research Council of South Africa, the Medical
Research Council of Zimbabwe and the Comité Nacional
de Bioética para a Saúde in Mozambique (the study coun-
tries); and at the London School of Hygiene and Tropical
Medicine and the World Health Organization (one of the
research funders). After being provided with information,
each respondent gave written informed consent for inter-
view. In reporting, we have removed any potential identi-
fiers.
Results
We present the findings for each of the case studies -
MgSO4 and malaria - across the three countries. For the
purposes of comparison, we have organised the findings
in each section around the key issues for knowledge trans-
lation emerging from our data. These findings are also
summarised in Table 2.
MgSO4 in the treatment of eclampsia and severe pre-
eclampsia
The research evidence
Landmark trials, subsequently incorporated into
Cochrane reviews, have demonstrated the efficacy of
MgSO4 in the treatment of eclampsia and pre-eclampsia in
pregnancy [23-27]. South Africa and Zimbabwe partici-
pated in these trials, which presented high quality evi-
dence for the use of this drug as a first line therapeutic.
Local involvement in evidence production
In all three countries, leading obstetric departments were
involved in trials of MgSO4, and the obstetricians con-
cerned participated in policy formulation, influencing
uptake of these research findings. In particular, senior
obstetricians and other researchers in South Africa and
Zimbabwe were involved in the Collaborative Eclampsia
and Magpie trials [26,27]. This enhanced the credibility of
the trial results within these settings:
"I think it [the Collaborative Eclampsia Trial] was pre-
sented at a number of local meetings. ... the leader in South
Africa of that trial, ... he presented it at many meetings and
so it was a well known research in this country and in Zim-
babwe." (Clinician/researcher, South Africa)
Involvement in these trials allowed local researchers to
gain further experience in the use of MgSO4 for the treat-
ment of eclampsia and pre-eclampsia. However, respond-
ents reported that adverse outcomes experienced by
patients receiving MgSO4 in the Collaborative Eclampsia
Trial in Zimbabwe raised concerns amongst clinicians
regarding its safety. This was thought to have inhibited its
uptake as first line treatment for eclampsia in the country.
Respondents in Mozambique reported that a trial con-
ducted locally in 1989 showed MgSO4 to be superior to
diazepam for the treatment of eclampsia. Although this
study was never published, it was considered important in
convincing obstetricians to use the drug:
"We developed the trial up to a certain point, but it was
obvious that the patients treated with magnesium sulphate
had a lower mortality, and they awoke more rapidly fromHealth Research Policy and Systems 2009, 7:31 http://www.health-policy-systems.com/content/7/1/31
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Table 2: Summary of study findings
Factors identified as 
influencing the use of 
research in 
policymaking
Case study 1: MgSO4 
for eclampsia
Case study 2: Bed nets 
versus spraying for 
malaria
Factors found in 
systematic reviews to 
influence the use of 
research in 
policymaking [11,13]
Comments
Research evidence High quality evidence from 
RCTs that supported the 
effectiveness of MgSO4 as 
first line treatment.
Head-to-head comparisons 
in RCTs did not find an 
important difference in 
effectiveness.
- Timeliness, perceived 
relevance and quality of the 
research
- Trust in the research and 
researchers
- Availability of research 
summaries with clear 
recommendations
- Use of jargon and only 
publishing for a scientific 
audience
- The perceived relevance 
and quality of the research 
on MgSO4 was high, 
whereas the evidence for 
bed nets was not perceived 
to be relevant. More 
weight was given to local 
experience than to 
evidence from RCTs for 
malaria control.
- Availability and timeliness 
of the research were not 
identified as important for 
either case.
Involvement of local 
researchers in evidence 
production
Leading obstetricians in all 
three countries were 
involved in the trials.
Researchers in South 
Africa involved in one 
comparative trial.
Researchers in 
Mozambique were involved 
in bed net research.
This was not identified as 
an important factor in 
either of the reviews cited 
above
Involvement in trials may 
be an important influence 
directly or through other 
routes. These other routes 
include champions, 
international networks, 
prior experience and the 
promotion of a culture of 
evidence-based health care.
Prior clinical or public 
health experience
Prior experience in the use 
of specific drugs for 
eclampsia may explain, in 
part, differences in policy 
between the three 
countries.
Prior experience heavily 
influenced support for 
spraying and inhibited 
policies favouring the use 
of bed nets.
Policy confirmatory 
research
The extent to which the 
research confirmed or 
challenged prior 
experience was important 
for both cases.
Research and policy 
champions
Obstetrician researchers 
championed MgSO4 in all 
three countries, but in 
Zimbabwe the key 
champion emigrated prior 
to development of a policy 
supporting MgSO4 as the 
first line drug.
Researchers regionally, 
particularly in South Africa, 
championed spraying, 
whereas researchers in 
Mozambique championed 
bed nets.
Neither review specifically 
identified the role of 
champions in promoting 
the use of research 
evidence, although both 
found interactions and 
trust between 
policymakers and 
researchers to be the most 
commonly identified factor 
supporting research use.
In both cases senior 
researchers actively 
advocated for specific 
policies. In the malaria case, 
researchers in South Africa 
and Zimbabwe advocated 
spraying rather than bed 
nets. In Mozambique, they 
advocated nets.
International networks, 
organisations and other 
stakeholders
International networks that 
influenced MgSO4 policy 
were largely evidence-
based, such as the 
Cochrane Collaboration.
A wide range of 
stakeholders and 
international organizations 
with differing interests, 
including bilateral donors, 
(e.g. DFID, JICA), and 
multilateral agencies, (e.g. 
WHO, UNICEF and the 
Roll Back Malaria 
Partnership), influenced 
malaria policy in 
Mozambique and 
Zimbabwe. This was 
partially due to donor 
dependence.
Neither review identified 
stakeholder interests or 
international networks as 
being important factors 
that affect the use of 
research, although 
community pressure was 
identified as an important 
factor.
It is likely that international 
organizations play a more 
important role in policy 
development in many 
LMICs compared to high-
income countries, due to 
donor dependence.Health Research Policy and Systems 2009, 7:31 http://www.health-policy-systems.com/content/7/1/31
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comas and convulsions ..." (Clinician/researcher,
Mozambique)
Interactions between research - both local and interna-
tional - and experiential knowledge therefore influenced
researcher-clinicians' acceptance of trial findings on the
effectiveness of MgSO4; the value attributed to them; and
the uptake of these findings into policies.
Prior practices and beliefs
While research knowledge was important in shaping pol-
icy and practice, experiential knowledge also played a key
role. Based on their clinical training, obstetricians in
South Africa and Mozambique tended to follow the
obstetric schools that promoted the use of MgSO4 for the
management of eclampsia:
"I think it depended on where people studied. It depended
on what people read and it depended on what people
believed." (Clinician/researcher, South Africa)
Because practice prior to the landmark trials was often
based on MgSO4, many obstetricians noted that they had
Regional networks of 
policy makers and 
researchers
Regional networks of 
policy makers and 
researchers did not 
emerge as an important 
factor.
Regional networks of 
policy makers and 
researchers emerged as a 
key factor influencing 
malaria policy.
Existence of policy 
networks
This difference between 
the two cases may reflect 
differences between public 
health policies, particularly 
for vector-borne diseases 
that cross borders, and 
policies for clinical 
interventions. In addition, 
powerful champions 
promoted regional 
networks for malaria policy 
and control.
Involvement of 
researchers in policy 
making
Researchers played an 
important role in policy 
development in all three 
countries.
Researchers played an 
important role in policy 
development in all three 
countries.
Interactions and trust 
between policymakers and 
researchers.
There was extensive 
interaction between 
researchers and policy 
makers in both cases, and 
researchers also moved 
between the research and 
policy environments. This 
level of interchange may be 
more common in LMICs 
than in high- income 
countries.
Culture of evidence-
based health care 
within specific health 
domains
This emerged as an 
important factor 
supporting the uptake of 
research findings for 
MgSO4, due to the strong 
culture of evidence-based 
health care in obstetrics.
The culture in relationship 
to evidence varied for 
malaria, with greater 
emphasis on local 
observational evidence. 
Differences in malaria 
epidemiology contributed 
to this emphasis.
Skill and attitudes of those 
receiving the research
The greater focus on local 
conditions and evidence 
may be more typical for 
public health and 
communicable diseases 
management particularly.
Political and 
bureaucratic processes
Bureaucratic processes can 
in part explain the failure 
to include MgSO4 in the 
national formulary in 
Mozambique even though 
it was recommended [30].
Political processes at 
national, regional and 
international levels may 
have contributed to the 
continuation of policies 
that failed to promote the 
use of bed nets.
- Bureaucratic process 
including power and budget 
struggles and conflicts
- Management support
Bureaucratic processes 
emerged as being 
potentially important for 
MgSO4, whereas political 
processes appeared more 
important for malaria 
policies.
Events within the wider 
political environment
Although this did not 
emerge as an important 
factor, political and 
economic instability may 
have influenced policy in 
Zimbabwe.
Political and economic 
changes influenced policy in 
several ways: through 
South Africa becoming 
influential in regional 
politics; through lobbying 
by interest groups; and 
with regard to ideological 
and political perceptions of 
spraying and bed nets.
The political environment 
including political stability 
and community pressure.
External political events 
can be a limiting factor, but 
are perhaps more 
important in public health 
than in clinical medicine.
Table 2: Summary of study findings (Continued)Health Research Policy and Systems 2009, 7:31 http://www.health-policy-systems.com/content/7/1/31
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experienced the clinical success of the drug long before it
was shown to be effective in trials:
"...even in the absence of a randomised study, I think the
empirical results were very convincing." (Clinician/
researcher, Mozambique).
Because the evidence from the later Collaborative Eclamp-
sia Trial [26] was congruent with existing practice, its
uptake into policy was easier.
In Zimbabwe, on the other hand, obstetricians tended,
before MgSO4 was demonstrated to be effective, to follow
the British tradition of using diazepam for eclampsia
management:
"...the older consultants have been trained in Britain and
came with what we were doing in Britain, and practising
what we were doing in Britain and this has been passed on
to the others in the country...." (Clinician/researcher,
Zimbabwe)
"... diazepam has been there for as long as I have been
there, even pre-independence [before 1980], diazepam has
been used all along...." (Clinician/researcher, Zimba-
bwe)
Champions and lobby groups
The role of, and need for, local champions in placing
issues on the policy agenda was highlighted. In all three
countries, clinical champions lobbied for MgSO4 to be
included as the first line treatment for eclampsia:
"Yes, both [clinicians] in private and in public practice
[lobbied], some as groups of researchers and others in their
individual capacities...." (Clinician/researcher, Zimba-
bwe)
Respondents in South Africa suggested that individual
and organizational lobbying drew attention initially to
the causes of maternal mortality, helping to place mater-
nal and child health on the policy agenda [39,40]. This
helped to ensure that the Department of Health priori-
tised the development of evidence-based policies to
improve maternal health. In Zimbabwe, clinical champi-
ons were also important in developing guidelines for the
treatment of eclampsia. Their importance was illustrated
by the fact that the emigration of the local champion for
MgSO4, before the full acceptance of the drug was realised,
was regarded by some as a cause for slowing the process of
getting MgSO4 into policy and practice for the manage-
ment of eclampsia.
Lobbying and championing was not limited to the
national level. Groups such as the Cochrane Collabora-
tion influenced how local researchers and policy makers
thought about evidence-based practice and policy, as we
discuss below.
Involvement in national and international research networks
In all three countries, academic obstetricians who were
key to local policy development were involved in
national, regional and international research networks.
These networks were influential in building a culture of
research and evidence-based medicine through exposing
local clinicians to these ideas as they developed interna-
tionally. Directly and indirectly, these networks therefore
shaped the translation of evidence into policies. For exam-
ple, our data indicated that proponents of evidence-based
obstetrics internationally, including several linked to the
then developing Cochrane Collaboration, participated in
conferences in South Africa:
"We actually invited [researchers]....  attached to the
Oxford Database [the precursor to the Cochrane
Library].... So we were sort of, I think from the word go,
when the Oxford Database became available for use, we
were part of it, we were aware of it, we were using it, and
I think quite a few South Africans became involved on their
editorial board and as editors or reviewers, or whatever."
(Clinician/researcher, South Africa)
Leading international researchers also spent sabbatical
periods, or developed research units, in the study coun-
tries. In Mozambique, international researchers working
in the capital facilitated access to the international litera-
ture and organised scientific exchanges:
"...studying abroad, having scientific interchanges not just
based on the diseases here, is important. The doctors who
come to work here help in training the Mozambican doctors
who work with them". (Clinician/researcher, Mozam-
bique)
These networks built links to key research taking place
internationally and to international policy debates on
treatment. Later these networks were also important in
recruiting researchers from the study countries into inter-
national trials of MgSO4.
Involvement of researchers in policy making
Key to knowledge translation in the case of MgSO4 was the
interface between researchers and policy-making. In all
three countries, academic obstetricians who were also
active as researchers played important roles in policy
development. These obstetricians worked with govern-
ment officials to draft and review policies, often through
expert groups. In Mozambique and Zimbabwe, they were
often given policy-making responsibilities, as a researcher
in Zimbabwe notes:Health Research Policy and Systems 2009, 7:31 http://www.health-policy-systems.com/content/7/1/31
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"The policy of management of eclampsia is enunciated in
the EDLIZ [Essential Drugs List of Zimbabwe] and is a
process of consultation within affiliated disciplines to arrive
at compilation of the document. Obstetricians and gynae-
cologists contributed to this through a nominated point per-
son who worked with the Ministry Steering Committee to
draw up this document." (Clinician/researcher, Zimba-
bwe)
Government officials also gave researchers other tasks,
such as drawing up operational plans, training and super-
vision, which contributed to close working relationships.
In Mozambique, some academic obstetricians also occu-
pied key positions in the Ministry of Health.
In contrast, limited opportunities existed for academics to
engage with government in South Africa prior to the
change of government in 1994. The new government,
however, prioritized maternal and child health and
employed into its ranks key members of the national aca-
demic obstetric community. This created opportunities
for academic engagement in this sector with key policy-
making committees being chaired by academic obstetri-
cians. A clinician researcher described this change in
researcher involvement in policy-making:
"...I've worked in obstetrics before the new government and
after, and ... before there was never the ability to talk about
national policies or anything like that. Certainly afterwards
[after 1994] there's been a great movement to be able to do
that, to participate and to make guidelines." (Clinician/
researcher, South Africa)
In all three countries, obstetricians thus had ready access
to policy makers and were part of tight-knit policy com-
munities. The closeness of academic obstetricians in each
country to the policy making process suggests that they
were potentially key conduits for knowledge translation.
A culture of evidence based obstetrics
Attempts have been made internationally to develop a
culture of evidence-based research and practice within
obstetrics [41]. In the study settings, a culture of basing
practice on research findings preceded the availability of
evidence from RCTs. We have already described how local
researchers became linked into international evidence-
based medicine networks. The success of these interna-
tional initiatives in the study countries was clear from our
interviews, with most respondents expressing strong views
on the importance of using and generating evidence:
"...so evidence, that sort of thing was really grasped with
both hands. I think a lot of our research is clinical. So trials
are our - if you want to do research -is our bread and butter
... I don't think there's any ...O & G [obstetric and gynae-
cology] academic institution which doesn't use Cochrane
extensively." (Clinician/researcher, South Africa)
Most respondents embraced strongly a culture of evi-
dence-based medicine, believing that policies should be
based on RCT findings. Since many of these clinicians
were key to the policy making process, their definitions of
evidence influenced strongly the sorts of information con-
sidered during policy development. Respondents placed
high value on evidence from RCTs, including the interna-
tional collaborative trials [26,27]. Respondents noted that
before evidence from these trials became available, other
forms of research information such as the Pritchard case
series on the treatment of eclampsia [42,43] were relied
upon:
"... in a very famous series of cases of Pritchard, they had
300 consecutive cases of eclampsia without any maternal
deaths ...with magnesium sulphate. That's clinical proof..."
(Clinician/researcher, Mozambique)
Insecticide treated bed nets compared with indoor residual 
household spraying for malaria vector control
The evidence
Indoor residual spraying and insecticide-treated nets have
been demonstrated to be effective across a wide range of
settings. However, few randomised trials have compared
directly the efficacy of bed nets and indoor residual insec-
ticide spraying and their comparative cost-effectiveness
depends on the context in which they are implemented. It
is therefore difficult to justify one approach over another
based on the available evidence [44,45]. At the time of the
study, there had also been no trials directly comparing dif-
ferent insecticides. In addition, long-term impregnated
nets had not been widely distributed in the study settings.
The stakeholders and international agencies
A large and diverse group of stakeholders was involved in
decisions on malaria policy in the three countries. Impor-
tant players included government officials; multilateral
agencies (particularly the WHO and UNICEF); partner-
ships such as the Roll Back Malaria Partnership (which
includes WHO, UNICEF, UNDP, the World Bank and a
wide range of other NGOs); foundations; donors (such as
the UK Department for International Development
(DFID); the Japan International Co-operation Agency
(JICA); and the Global Fund against AIDS, Tuberculosis
and Malaria); academic and private sector institutions;
NGOs (such as environmental organisations); political
actors; and commercial actors (such as insecticide manu-
facturers). These stakeholders expressed varied and con-
tested interests, differed in their use and interpretation of
evidence, and promoted different malaria control poli-
cies, as we describe elsewhere [46]. Contested issues
included which insecticide to use (all three countries) andHealth Research Policy and Systems 2009, 7:31 http://www.health-policy-systems.com/content/7/1/31
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whether to use nets or spraying (Mozambique). Political
and commercial interests were also evident, and these
interests attempted to influence both policy makers and
researchers. For example, the tobacco lobby in Zimbabwe
was important in the decision to stop using DDT because
of fears that the pesticide would contaminate the tobacco
crop.
" [The] tobacco commercial farming sector lobbied govern-
ment against use of DDT because the buyers of Zimbabwe
tobacco abroad were saying that, if they found traces of
DDT in tobacco, they would not buy Zimbabwe tobacco."
(International agency, Zimbabwe)
In Mozambique, younger researchers mostly favoured the
introduction of bed nets. This was because they had been
drawn into international bed net research networks
through their post-graduate studies overseas and through
their contacts with international researchers visiting and
working in Mozambique. Because of its higher malaria
burden, Mozambique was more integrated than were
South Africa and Zimbabwe into the international malaria
research networks that had undertaken key RCTs on ITNs.
Bilateral donors, multilateral agencies, and international
NGOs were important players in shaping malaria control
policies, particularly through funding ITN programmes in
Mozambique and Zimbabwe:
"...but of course the insecticide treated nets agenda is also
pushed, as you may be aware, very strongly by the bilateral
donors, and other players and the UN family and so on.
And so the government has accepted their advice as it were,
of course to actually use nets ...Nets, to begin with, I think,
were an outside sort of influence" (International agency,
Zimbabwe)
"We can see that nets have become an international fash-
ion... there is a lot of pressure regarding them..." (Govern-
ment health official, Mozambique)
Pesticide and net manufacturers also lobbied for their
interests and contributed to developing and shaping evi-
dence. For example, pesticide companies had an interest
in promoting insecticides other than DDT for spraying, as
greater profits were to be made from newer insecticides.
These companies therefore sponsored trials in both
Mozambique and Zimbabwe [47-49].
A range of NGOs also worked to influence malaria control
policies. Environmental lobby groups, both local and
international, played important roles in supporting
moves away from DDT in South Africa and Zimbabwe in
the 1990s and in mobilising evidence for this:
"The international community, as you probably know, the
Greenpeace people and the environmental lobbying groups
started putting pressure...we agreed in principle to try
reducing the reliance on DDT mainly because of all the
things that were published. So those are more or less the
reasons why we moved towards reducing DDT." (Govern-
ment official, South Africa)
Later, the NGO 'Africa Fighting Malaria' took on the task
of lobbying for DDT http://www.fightingmalaria.org. This
organization, apparently linked to international neocon-
servative groups [50], fiercely criticized environmentalists
who had pushed for a ban on DDT [51].
The role of regional networks of policy makers and researchers
Researchers and policy makers were organised into strong
regional networks that were important in sharing ideas
and approaches to malaria control. These networks played
a key role in maintaining the emphasis on spraying in the
region.
Historically, South Africa and Zimbabwe had close links
and several key South African researchers and malaria
control officers had been trained, and formerly held posi-
tions, at the Blair Research Institute in Harare - an impor-
tant regional malaria research institution. Strong
relationships later developed between South African and
Mozambican researchers and implementers around the
Lubombo Spatial Development Initiative (LSDI), which
aimed to improve malaria control in South Africa, Swazi-
land and neighbouring areas of Mozambique.
Involvement of researchers in policy making
Although policy makers may have become aware of
research evidence through their own reading, respondents
also identified a number of interfaces through which
research entered the policy making process. Firstly,
researchers were co-opted into formal government advi-
sory committees in all three settings:
"...certainly we [in the government department] might
have the background knowledge into it but we're not cur-
rently working in researching malaria all the time... So we
felt that we needed to bring and call on expertise from the
country to advise us on policy ... and that is the main reason
why the decision was taken to put an advisory group
together." (Government official, South Africa)
Consequently, close relationships developed between
researchers and health officials responsible for imple-
menting malaria control. These researchers were regarded
as experts and evidence uptake was mediated through
them.Health Research Policy and Systems 2009, 7:31 http://www.health-policy-systems.com/content/7/1/31
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Secondly, researchers acted in some instances not only as
advisors but also as implementers. For example, a senior
researcher in South Africa was integrally involved in
implementing malaria control initiatives within the LSDI.
This initiative, which integrated research and implemen-
tation, helped to bring researchers and policy makers
together, as one researcher involved in this noted:
"...we brought service and research together. We thought,
'What's happening in the world? There's a lot of research
going on but is it translating into implementation?'. I think
that you have to bring those two communities together
because the one needs to feed into the other... Over the last
ten years, maybe fifteen, we've really worked towards trying
to bridge that gap." (Researcher, Mozambique)
Thirdly, national research bodies had close links with gov-
ernment policy-making bodies in all three countries:
"I think major advantages that Blair [the Blair Research
Institute] has made, or Blair research findings had in influ-
encing policy, is that Blair themselves are part of the
national malaria control programme, and Blair do sit in
national malaria control programme committees. So the
work that they do and their research findings find [their]
way almost automatically, naturally into policy and deci-
sion making." (International agency, Zimbabwe)
Knowledge translation for malaria control was facilitated
through these different avenues.
Defining 'evidence' in the context of malaria control
In contrast to the MgSO4 case study, there seemed to be a
less visible culture of decision-making for malaria control
being based on RCT evidence. Respondents were clear
that, for them, what constituted research evidence went
beyond RCTs and included experience, surveillance data
and expert opinion. Considerable research was under-
taken locally in all three countries. This research - broad in
its methodological approach - was regarded as important
to decision making. For example, the malaria surveillance
data collected for many years in Zimbabwe and South
Africa were seen as important evidence for shaping policy
(see, for example, [52]), particularly in showing the effec-
tiveness of the spraying approaches used in these settings.
The weight of this evidence meant that RCTs were not seen
as necessary to demonstrate the effectiveness of spraying:
"But in terms of indoor residual spraying, I think the evi-
dence is not disputable - it's there to see! In the countries
where indoor residual spraying is done, the number of
malaria deaths are very low, but in countries where indoor
residual spraying is not being done, the number of malaria
deaths are so high." (Government health official, Zim-
babwe)
In Zimbabwe and South Africa, the international evidence
from ITN trials was also seen as distant and not necessarily
relevant as it was felt that the local epidemiology of the
disease was different to that of the countries in which the
trials were conducted:
"Well I know with nets, even up to now there are a lot of
controversies. The epidemiology of malaria in Zimbabwe is
quite different from Tanzania, is quite different from the
Gambia, or where there is high para-endemicity in those
areas" (International agency, Zimbabwe)
Although a national trial comparing bed nets and spray-
ing was conducted in South Africa in the 1990s [53-55],
this was stopped when a malaria epidemic demanded
quick action that undermined the trial randomisation.
In addition to concerns about the local applicability of
RCT evidence, many policy makers were also clear that
ease of implementation and sustainability were key to
their decision-making regarding malaria control options.
Simply showing success in a RCT was not considered suf-
ficient:
"Several randomised and controlled studies have already
been undertaken which prove effectiveness in reducing mor-
tality, but how can this ideal situation be translated into
practical terms, while maintaining effectiveness?... In prac-
tical terms and under real conditions,... this is where ques-
tions arise. Why are there so many nets distributed, and
why are there so many sprayings, and there is no positive
impact? ...Research should always be done; otherwise we
will not be able to know when an intervention is no longer
working." (Researcher, Mozambique)
"... after five years of investment in the Gambia (teams,
money, very high cost), when they [the researchers] left, it
all fell apart. People need to learn the advantage of
nets...because the nets give more work. ...it is a long-term
thing to create a habit. (Policy maker, Mozambique)
Some respondents within the malaria control programme
also differentiated between research, and surveillance and
outbreak investigation:
"We have very little time for actual research. [...] It's basic
problem solving. If there's a small outbreak or a rise in cases in
a particular area, you go there and try and evaluate and see
what the reason for it is. So you can't study or work in one area
for a particular time, which virtually rules out any kind of
research." (Government official, South Africa)
While research evidence was regarded as influential, many
respondents saw local experience with varied approaches
to malaria control as even more important. Thus, the longHealth Research Policy and Systems 2009, 7:31 http://www.health-policy-systems.com/content/7/1/31
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history of spraying in the region contributed to a prefer-
ence for its continued use:
"Historical evidence - there was plenty...50 years of spray-
ing in South Africa with large areas free from malaria that
previously had been malarious areas." (Researcher,
Mozambique)
This contributed to the delayed acceptance of bed nets in
Mozambique and Zimbabwe and to scepticism towards
this control approach in South Africa.
Discussion
Our knowledge translation findings are similar to those
synthesized by Innvær in a systematic review of research
on the use of evidence by health policy makers [13]. Fac-
tors identified by this review, such as interaction and trust
between policy makers and researchers, are consistent
with our findings for MgSO4. Similarly, we found the
political environment to be important in both the MgSO4
and malaria cases: democratization in South Africa was a
factor enabling the MgSO4 research findings to be taken
up into policy. Furthermore, the changed political envi-
ronment in southern Africa after the democratic elections
in South Africa in 1994 affected regional malaria policy.
The importance of policy networks involving policy mak-
ers and researchers, and the influence of political factors
such as local conflicts, were also highlighted as important
in a more recent systematic review of factors affecting
research utilisation by health policy makers and health
care managers [11].
In our study, there were similarities across the case studies
regarding the routes through which research entered the
policy making process; the influence of lobby groups and
champions; and the roles of national, regional and inter-
national research and policy networks. In addition, simi-
larities were found in the use of field or clinical
experience; conceptions of what constituted "evidence";
and the extent of local involvement in evidence produc-
tion. However, the relative importance of these factors
was different for eclampsia and malaria, as we discuss
below.
In both Mozambique and Zimbabwe, and to some extent
South Africa, the relatively small number of health care
clinicians/researchers, policy makers and institutions ena-
bled a greater degree of interaction between them and
contributed to the frequent movement of researchers
between the research and policy domains. This contrasts
with the situation in many high-income countries, where
there is often a greater breadth of health personnel and
institutions and where it is therefore likely that a lower
proportion of senior researchers are involved directly in
policy-making.
In the case of policy for the management of eclampsia,
obstetricians and researchers in all three countries tended
to belong to the same national clinical and research net-
works and attended the same meetings and conferences.
We would therefore suggest that this tightly knit, exclusive
group constituted a "policy community" [56,57]. These
national policy communities in Zimbabwe and South
Africa were linked closely to the Cochrane Collaboration,
which played a particularly important role in ensuring a
common conceptualisation of "evidence"; providing
resources; and lobbying for and facilitating knowledge
translation. The existence of these tightly knit national
policy communities, consisting of a small number of cli-
nicians with similar backgrounds and training, also ena-
bled consensus regarding what constituted research
evidence. As alluded to above, champions were more
important for knowledge translation in the eclampsia case
study than in the malaria case. We would suggest that this
is because the policy communities for eclampsia manage-
ment were fairly homogenous and small, being formed
mainly of obstetricians. Under these circumstances,
champions have considerable influence. Other studies
have also suggested that such popular opinion leaders
have more influence within tightly knit groups [58-60]
and may be particularly important in influencing others
to adopt new approaches, technologies and treatments.
In contrast, we identified a much wider array of stakehold-
ers within the malaria control domain. These groups, with
divergent backgrounds, opinions and interests, more
closely resemble issue networks in which relations between
actors are looser than in policy communities [56,57]. The
actors within these networks were an "unruly mélange"
[61] of interest groups and political actors, often contest-
ing existing and new interventions and championing dif-
ferent causes, based on ideological, political and
commercial interests. In the debates regarding malaria
control, which included which insecticide to use and
whether or not to use bed nets or spraying, various groups
were aligned with different positions. For example, there
were pro- and anti-spraying groups among government
officials, researchers and politicians in all three countries,
and WHO regional and central offices were often on dif-
ferent sides of the ITN debate.
Eclampsia, as a clinical condition, therefore has a narrow
"footprint" in the sense that the range of actors involved
is fairly narrow - they are more likely to have close work-
ing relationships and to have developed a common
understanding of the research "evidence". In contrast,
malaria control has a broad "footprint", with a very wide
range of actors with differing agendas in both the research
and policy areas. This makes development of a common
understanding of "evidence" more difficult.Health Research Policy and Systems 2009, 7:31 http://www.health-policy-systems.com/content/7/1/31
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Another important factor in knowledge translation was
the extent of local involvement in knowledge production.
Where local researchers were involved in international
multi-centre studies, such as the Collaborative Eclampsia
Trial [26], or undertook national studies, the findings
were seen as having greater credibility and applicability
within the country context. This can be partly explained
by the need for research to be relevant to the local epide-
miology of disease and to health service organization.
However, familiarity with the intervention was also
important and, for example, was one of the reasons why
bed nets did not receive significant attention from policy
makers within the National Department of Health in
South Africa.
The overall political and economic context in which
knowledge translation took place was also important. The
change of government in 1994 in South Africa, for exam-
ple, brought in a new cohort of policy makers who ques-
tioned the longstanding use of DDT for spraying. This
influenced the subsequent decision to switch to the use of
pyrethroid insecticides for spraying. Similarly, this change
in the political context also resulted in far greater empha-
sis being placed on maternal and child health. This in
turn, provided an opportunity to introduce national
guidelines for the management of eclampsia based on
MgSO4. Such "policy windows" [62] are important in
understanding why knowledge translation took place in
specific context at particular times.
In exploring the role of research evidence in policy-mak-
ing, this study raises a number of methodological issues.
Firstly, it draws heavily on the accounts of respondents. A
strength of this approach is that the data represent the
views of those closely involved in formulating the policies
studied and therefore provide valuable insights into pol-
icy processes. However, we recognise that such accounts
are inevitably influenced by respondents' position at the
time of the event, their position now, their relationship
with the researchers, the shifts that they may have made
over time between organizations and their memory of
particular events [63]. To address this, we attempted to tri-
angulate interview data with information from other
sources. Secondly, the purposive sampling draws in part
on identifying respondents through others familiar with
the policymaking process, and this may have yielded a
sample of people sharing similar opinions. To avoid this,
we actively sought respondents with differing views and
explored negative cases [38]. Thirdly, this study did not
address policy implementation, focusing rather on policy
development. Further studies are required to explore the
ways in which policies for maternal health and malaria
control have been implemented in the field. Fourth, this
paper attempts to summarise findings across three coun-
tries and two case studies and therefore cannot do full jus-
tice to the depth of data collected in each site. More
detailed reports of components of this work are available
[30,46,64]. Finally, the case study approach, like many
qualitative methods, has been criticized for being unable
to produce generalisations. We would argue, though, that
the approach allows theoretical generalisability [65] and
provides insights into the ways in which knowledge
informs policy making in 'real life' contexts [66].
Key lessons learnt from the study are:
￿ There is openness among policy stakeholders to consid-
ering research findings. International efforts to support
the use of research evidence in LMICs should therefore
continue.
￿ Local researchers were more open to the findings of
research in which they had been involved.
￿ Local champions are important and are a potential route
for facilitating knowledge transfer. They should therefore
be supported.
￿ National, regional and international networks appear to
be very important in both shaping ideas about what con-
stitutes evidence and in acting as a conduit for transfer of
research findings. This can have both positive and nega-
tive impacts. For example, views regarding the effective-
ness of spraying within policy networks operating in
Zimbabwe and South Africa may have reduced openness
to considering the use of bed nets.
￿ Context is an important filter for the translation of
knowledge at local levels. Issues such as the local applica-
bility of evidence, and the extent to which proposed poli-
cies differ from what is currently believed or the status
quo, are aspects of this. Strong international evidence may
therefore not always be locally accepted.
￿ Skills and ability to act on research evidence was present
in all of the study settings. However, the capacity for
absorption was limited by human and other resource con-
straints. For example, knowledge translation was often
dependant on a few key people or on a particular array of
conditions/circumstances. The process is therefore a frag-
ile one.
Conclusion
The World Health Organization has noted that "Stronger
emphasis should be placed on translating knowledge into
action to improve public health by bridging the gap
between what is known and what is actually being done."
[8] p. xv). This study illustrates that translating research
knowledge into policy and practice is a complex and con-
text sensitive process. Interaction and trust between poli-Health Research Policy and Systems 2009, 7:31 http://www.health-policy-systems.com/content/7/1/31
Page 13 of 14
(page number not for citation purposes)
cymakers and researchers were important factors in the
use of research in policymaking in the study settings, as
were political and bureaucratic processes, policy confirm-
atory research and the relevance and quality of the
research. Research champions and international networks
were also important, though these factors have not been
emphasised in systematic reviews of factors affecting pol-
icy makers' use of evidence. Efforts to support knowledge
translation in LMICs need to both take account of these
factors and incorporate evaluation, so that a wider evi-
dence base for knowledge translation in these settings can
be developed.
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